Stimulants and ADHD
Ritalin®, Concerta® Adderall®, amphetamines and other stimulant medications

DocumentsDate added

Order by : Name | Date | Hits [ Ascendant ]
file icon Intoxication Anosognosia (Medication Spellbinding) 06/09/2008
file icon Psychostimulants in the treatment of children diagnosed with ADHD 01/01/2008
"Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanisms of action," International Journal of Risk & Safety in Medicine 12 (1999).
file icon What psychologists and therapists need to know about ADHD and stimulants 02/01/2007
Dr. Breggin appeals to counsellors and other mental health professionals, protesting the systematic drugging of children.
file icon Confirming the hazards of stimulant drug treatment 03/13/2006
Examining the hazards of stimulant therapy (Ritalin and amphetamine) in children.
file icon The NIMH multimodal study of treatment for attention-deficit/hyperactivity disorder 04/29/2005

International Journal of Risk & Safety in Medicine 13 (2000).

A careful review of the Multimodal Treatment Study for Attention-Deficit/Hyperactivity Disorder (the 'MTA Study') reveals serious methodological flaws that undermine its scientific validity.

file icon NIH consensus report highlights controversy surrounding ADHD diagnosis and stimulant treatment 01/15/2005
"NIH Consensus Report Highlights Controversy Surrounding ADHD Diagnosis and Stimulant Treatment," Ethical Human Sciences and Services, Vol 1 No 1 (1999).
file icon Sedative-like effect of epinephrine 01/28/1970

"The Sedative-Like Effect of Epinephrine," Arch Gen Psych Vol 12 (1965).

Recent findings have created the need for a review of the literature concerning epinephrine-induced behavioral depression and for an evaluation of the possible mechanisms and clinical implications.

file icon The psychophysiology of anxiety 01/01/1970

 

 

Dr. Peter Breggin and Colleagues
Launch New Reform Organization &
Annual Spring Conference
 

Peter R. Breggin, MD is no longer affiliated with the Center for the Study of Psychiatry, informally known as International Center for the Study of Psychiatry and Psychology, which he founded and led from 1972-2002, and Dr. Breggin will not participate in its conferences.   Dr. Breggin and his colleagues will hold their new annual spring conference April 8-10, 2011.  Details are available at http://www.empathictherapy.org.

 

 

WARNING!

Most psychiatric drugs can cause withdrawal reactions, sometimes including life-threatening emotional and physical withdrawal problems. In short, it is not only dangerous to start taking psychiatric drugs, it can also be dangerous to stop them. Withdrawal from psychiatric drugs should be done carefully under experienced clinical supervision. Methods for safely withdrawing from psychiatric drugs are discussed in Dr. Breggin's books, Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock and the Psychopharmaceutical Complex (New York: Springer Publishing Company, 2008) and Medication Madness: The Role of Psychiatric Drugs in Cases of Violence, Suicide and Crime (New York: St. Martin's Press, 2008).